| Name | Title | Contact Details |
|---|
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.
MLS Logistics is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Invivo Corporation is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
CTI Molecular Imaging Inc is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Pro Surg Inc is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.